Atrial fibrillation in incident dialysis patients

Kidney International

Volumn 76, Issue 3, 2009, Pages 324-330

  Vazquez, Eduardo ^a,c   Sanchez Perales, Carmen ^b   Garcia Garcia, Francisco ^a   Castellano, Patricia ^a   Garcia Cortes, Maria Jose ^b   Liebana, Antonio ^b   Lozano, Cristobal ^a  

^a Division of Cardiology   (Spain)

^b Nephrology   (Spain)

^c NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CALCIUM; CHOLESTEROL; CREATININE; FERRITIN; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN; HOMOCYSTEINE; PARATHYROID HORMONE; PHOSPHORUS; TRANSFERRIN; TRIACYLGLYCEROL; UREA;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CALCIFICATION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART BUNDLE BRANCH BLOCK; HEART EJECTION FRACTION; HEMODIALYSIS PATIENT; HEMOGLOBIN DETERMINATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PULSE PRESSURE; RISK FACTOR; SEX RATIO; THROMBOCYTE;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RENAL DIALYSIS; SPAIN; STROKE; SURVIVAL ANALYSIS;

EID: 67651124821     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2009.185     Document Type: Article

References (39)

1. Zoccali C, Mallamaci F, Tripepi G. Traditional and emerging cardiovascular risk factors in end-stage renal disease. Kidney Int 2003; 63: S105-S110.
2. Dikow R, Adamczak M, Henriquez DE et al. Strategies to decrease cardiovascular mortality in patients with end-stage renal disease. Kidney Int 2002; 61: S5-S10.
3. Ezekowitz MD. Atrial fibrillation: the epidemic of the new millennium. Ann Intern Med 1999; 131: 537-538.
4. Go AS, Hylek EM, Phillips KA et al. Prevalence of diagnosed atrial fibrillation in adults. National implications for rhythm management and troke prevention. The anticoagulation and risk factors in atrial fibrillation (ATRIA) study. JAMA 2001; 285: 2370-2375.
5. Korantzopoulos P, Kokkoris S, Liu T et al. Atrial fibrillation in end-stage renal disease. Pacing Clin Electrophysiol 2007; 30: 1391-1397.
6. Reinecke H, Brand E, Mesters R et al. Dilemmas in the Management of Atrial Fibrillation in Chronic Kidney Disease. J Am Soc Nephrol 2009; 20: 705-11.
7. Atar I, Konas D, Acikel S et al. Frequency of atrial fibrillation and factors related to its development in dialysis patients. Int J Cardiol 2006; 106: 47-51.
8. Vazquez E, Sanchez-Perales C, Borrego F et al. Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis. Am Heart J 2000; 140: 886-890.
9. Genovesi S, Pogliani D, Faini A et al. Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients. Am J Kidney Dis 2005; 46: 897-902.
10. Vázquez-Ruiz de Castroviejo E, Sánchez-Perales C, Lozano-Cabezas C et al. Incidence of atrial fibrillation in hemodialysis patients. A prospective long-term follow-up study. Rev Esp Cardiol 2006; 59: 779-784.
11. Genovesi S, Vincenti A, Rossi E et al. Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients. Am J Kidney Dis 2008; 51: 255-262.
12. Heeringa J, van der Kuip DA, Hofman A et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 2006; 27: 949-953.
13. Kannel WB, Wolf PA, Benjamin EJ et al. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based stimates. Am J Cardiol 1998; 82: 2N-9N.
14. Okin PM, Wachtell K, Devereux RB et al. Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension. JAMA 2006; 296: 1242-1248.
15. Psaty BM, Manolio TA, Kuller LH et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997; 96: 2455-2461.
16. Mitchell GF, Vasan RS, Keyes MJ et al. Pulse pressure and risk of newonset atrial fibrillation. JAMA 2007; 297: 709-715.
17. Lentine KL, Rocca-Rey LA, Bacchi G et al. Obesity and cardiac risk after kidney transplantation: experience at one center and comprehensive literature review. Transplantation 2008; 86: 303-312.
18. Tsang TS, Barnes ME, Miyasaka Y et al. Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years. Eur Heart J 2008; 29: 2227-2233.
19. Maher ER, Pazianas M, Curtis JR. Calcific aortic stenosis: a complication of chronic uraemia. Nephron 1987; 47: 119-122.
20. Mazzaferro S, Coen S, Bandini I et al. Role of ageing, chronic renal failure and dialysis in the calcification of mitral annulus. Nephrol Dial Transplant 1993; 8: 335-340.
21. Mellino M, Salcedo EE, Lever HM et al. Echographic-quantified severity of mitral annulus calcification: prognostic correlation to related hemodynamic, valvular, rhythm, and conduction abnormalities. Am Heart J 1982; 103: 222-225.
22. Nair CK, Runco V, Everson GT et al. Conduction defects and mitral annulus calcification. Br Heart J 1980; 44: 162-167.
23. Vázquez Ruiz de Castroviejo E, Sánchez Perales C, López López J et al. Prevalence of and predisposing factors for bundle branch block in patients starting dialysis. Rev Esp Cardiol 2008; 61: 719-725.
24. Ansari N, Manis T, Feinfeld DA. Symptomatic atrial arrhythmias in hemodialysis patients. Ren Fail 2001; 23: 71-76.
25. Dittrich HC, Pearce LA, Asinger RW. Stroke prevention in atrial fibrillation investigators left atrial diameter in non-valvular atrial fibrillation: an echocardiographic study. Am Heart J 1999; 137: 494-499.
26. Tsang TS, Barnes ME, Bailey KR et al. Left atrial volume: important risk marker of incident atrial fibrillation in 1655 older men and women. Mayo Clin Proc 2001; 76: 467-475.
27. Sarkar S, Ritscher D, Mehra R. A detector for a chronic implantable atrial tachyarrhythmia monitor. IEEE Trans Biomed Eng 2008; 55: 1219-1224.
28. Vázquez E, Sánchez-Perales C, Lozano C et al. Comparison of prognostic value of atrial fibrillation versus sinus rhythm in patients on long-term hemodialysis. Am J Cardiol 2003; 92: 868-871.
29. Benjamin EJ, Wolf PA, D'Agostino RB et al. Impact of atrial fibrillation on the risk of death. The Framingham heart study. Circulation 1998; 98: 946-952.
30. Stewart S, Carole LH, Hole DJ et al. A population-based study of the longterm risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Oausket study. Am J Med 2002; 113: 359-364.
31. Vidalillet H, Granada JF, Chyou PH et al. A population-based study of mortality among patients with atrial fibrillation or flutter. Am J Med 2002; 113: 365-370.
32. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991; 22: 983-988.
33. Wiesholzer M, Harm F, Tomasec G et al. Incidence of stroke among chronic hemodialysis patients with non-rheumatic atrial fibrillation. Am J Nephrol 2001; 21: 35-39.
34. Vazquez E, Sanchez-Perales C, Garcia-Cortes MJ et al. Ought dialysis patients with atrial fibrillation be treated with oral anticoagulants? Intern J Cardiol 2003; 87: 135-139.
35. Abbott KC, Trespalacios FC, Taylor AJ et al. Atrial fibrillation in chronic dialysis patients in the United States: risk factors for hospitalization and mortality. BMC Nephrol 2003; 4: 1.
36. Sanchez-Perales C, Vazquez E, Garcia-Cortes MJ et al. Antiplatelet therapy and risk of bleeding in hemodialysis patients. Nefrología 2002; 5: 456-462.
37. To AC, Yehia M, Collins JF. Atrial fibrillation in haemodialysis patients: do the guidelines for anticoagulation apply? Nephrology (Carlton) 2007; 12: 441-447.
38. Bennet WM. Should dialysis patients ever receive warfarin and for what reasons? Clin J Am Soc Nephrol 2006; 1: 1357-1359.
39. Quinn RR, Naimark DM, Oliver MJ et al. Should hemodialysis patients with atrial fibrillation undergo systemic anticoagulation? A cost-utility analysis. Am J Kidney Dis 2007; 50: 421-432.